Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 May 12;57(4):369–373. doi: 10.1007/s10593-021-02914-6

Synthesis of biologically active derivatives of 2-aminobenzothiazole

Larisa V Zhilitskaya 1,, Nina О Yarosh 1
PMCID: PMC8113786  PMID: 33994555

Abstract

graphic file with name 10593_2021_2914_Figa_HTML.jpg

The minireview considers the current trends in the synthesis of some biologically active compounds based on 2-aminobenzothiazole. The presented information covers publications of the last five years.

Keywords: 2-aminobenzothiazole, biological activity, green chemistry, multicomponent reaction, multistage synthesis, one-pot synthesis


Benzothiazoles (BTAs) are an important class of bicyclic heterocycles that play a key role in the design of biologically active compounds. At the moment, due to the threat of outbreaks of epidemics associated with the emergence and spread of various viruses (Zika, Lassa, SARS-Cov, etc.), modern research and development in medicinal chemistry and pharmacology based on benzothiazole derivatives have become especially relevant. Recently, the number of publications devoted to the synthesis and study of the pharmacological properties of 2-aminobenzothiazole derivatives has increased significantly. Several review articles are also devoted to this topic.1 Molecules with a benzothiazole moiety have a pronounced spectrum of biological activity, exhibiting, along with antiviral,25 also antimicrobial,610 anti-inflammatory,1015 antidiabetic,14 analgesic,12,13 antioxidant,6,14,15 antidepressant, 16 anticonvulsant,17,18 antianginal,19 antitumor, 20,21 immunomodulatory effects. BTA derivatives also have anthelmintic,6,7 antimalarial,23 fungicidal,6,24 insecticidal,24,25 and herbicidal26 effects.

This minireview concisely summarizes the main methods for the preparation of 2-aminobenzothiazole derivatives which include both one-pot and multistep synthesis methods. Their analysis will contribute to the development of targeted synthesis of benzothiazole analogs.27,28

In a number of recent studies, the synthesis of BTA derivatives was carried out in the context of the concept of green synthesis. One-pot multicomponent reactions with the participation of 2-aminobenzothiazole are a promising trend in the synthesis of its bioactive derivatives. They have a number of advantages: they are simple in experimental execution, are characterized by high yields of the target products in a relatively short reaction time, and more often proceed in the absence of a solvent. In most reactions, H2O is used as a nontoxic and widely available solvent which significantly reduces the cost of the process paving the way for the development of science and technology of the future.29 In this case, catalytic reactions are priority, allowing to reduce the impact on the environment.

One example of a green multicomponent synthesis is the three-component reaction of 2-aminobenzothiazole with aromatic aldehydes and 1,3-diketones under microwave irradiation in the absence of a solvent using Sc(OTf)3 as an initiator (Scheme 1).30 The method is based on a tandem reaction involving activation of the carbonyl group, the Knoevenagel condensation, nucleophilic addition of an azole followed by intramolecular cyclization to obtain products 1.

graphic file with name 10593_2021_2914_Sch1_HTML.jpg

Scheme 1

The multicomponent reaction between 2-aminobenzothiazole or its 6-substituted derivatives, indole-3-carbaldehyde, and aryl isocyanides in the presence of a heterogeneous acid catalyst P2O5 on a SiO2 support leading to 3-amino-2-(indol-3-yl)imidazo[2,1-b][1,3]benzothiazoles 2 is another example.31 In this case, the strong dehydrating properties of P2O5/SiO2 make it possible to quickly remove H2O released as a result of the reaction. The authors used a green protocol including environmentally friendly protic solvents (MeOH, EtOH) and easy catalyst regeneration (washing with hot EtOH and vacuum drying for 1 h, minimal loss of activity with repeated use) (Scheme 2).

graphic file with name 10593_2021_2914_Sch2_HTML.jpg

Scheme 2

A similar approach was used by Nouri et al.32 The p-TSAcatalyzed reaction of 2-aminobenzothiazole, arylglyoxal monohydrates, and 2-hydroxy-1,4-naphthoquinone in H2O–Me2CO, 2:1 was carried out in the presence of Et3N (p-TSA–Et3N, 1:1) at room temperature (Scheme 3). Mild reaction conditions, readily available catalysts, ease of isolation, and good yields of compounds 3 (78–84%) ensure the environmental safety and efficiency of the method.

graphic file with name 10593_2021_2914_Sch3_HTML.jpg

Scheme 3

A multicomponent technique for constructing spiroheterocycles annulated with biologically active scaffolds was developed by Kumar et al.33 Specifically, the pseudofour-component reaction of 2-amino-6-bromo-4-methylbenzothiazole, 4-methoxybenzaldehyde, 4-hydroxycoumarin in the presence of sulfamic acid for 10 min led to the target product 4 in 93% yield (Scheme 4). The proposed mechanism involves an acid-catalyzed cascade of the Knoevenagel reaction, condensation of the second aldehyde molecule with 2-aminobenzothiazole, and Diels–Alder heterocycloaddition of intermediates. EtOH also proved to be an effective solvent for the reaction (yield 92%, reaction time 21 min). The synthesis of 11 more compounds is described.

graphic file with name 10593_2021_2914_Sch4_HTML.jpg

Scheme 4

Arab-Salmanabadi34 synthesized a series of 20 functionalized bisthiazoles 5 and 6 in high yields (70–90%) via the reaction of 2-aminobenzothiazole with various α-halo ketones (bromo ketone, alkyl-2-chloroacetylacetone) in the presence of a sulfide nucleophile (carbon disulfide, aryl isothiocyanate) in an inert solvent. The formation of bisthiazoles involves the addition of carbon disulfide to 2-aminobenzothiazole, condensation of the adduct with α-halo ketone, enolization of the resulting intermediate, and cyclization with elimination of H2O (Scheme 5).

graphic file with name 10593_2021_2914_Sch5_HTML.jpg

Scheme 5

Another method for obtaining the target biologically active 2-aminobenzothiazole derivatives is a sequential multistep synthesis based on commercially available substrates and reagents.

Galochkina et al.2 synthesized tricyclic derivatives of imidazo[2,1-b][1,3]benzothiazolones 7 in two steps (Scheme 6). In the first step, 2-aminodihydrobenzothiazol-7-ones were formed in situ in the reaction of 1,3-diketones with Br2 and thiourea which were then involved in the alkylation reaction with aromatic and heteroaromatic α-halo ketones followed by intramolecular cyclization.

graphic file with name 10593_2021_2914_Sch6_HTML.jpg

Scheme 6

Bala et al.10 reported on a multistage method for the preparation of a series of benzothiazole-4-formylpyrazoles 8 (Scheme 7). Oxidative cyclization of aniline derivatives with ammonium thiocyanate and Br2 followed by hydrazinolysis of the corresponding 2-aminobenzothiazoles gave rise to 6-substituted 2-hydrazinylbenzothiazoles, the subsequent condensation of which with aromatic ketones in alcohol leads to benzothiazole hydrazones. Hydrazones were transformed into target products 8 in 65–85% yields by the Vilsmeier–Haack reaction.

graphic file with name 10593_2021_2914_Sch7_HTML.jpg

Scheme 7

Tarik et al.12 showed that 2-mercaptobenzothiazole (captax) or 5-chloro-2-mercaptobenzothiazole can be successfully used to obtain derivatives of 2-hydrazinobenzothiazoles. By heating the mercapto derivatives of benzothiazole in EtOH under reflux and subsequent condensation of the obtained 2-hydrazinobenzothiazole derivatives with oxadiazoles in dry pyridine, a series of unusual 1,2,4-triazoles 9 based on benzothiazol-2-amine were synthesized in good yields (Scheme 8).

graphic file with name 10593_2021_2914_Sch8_HTML.jpg

Scheme 8

The formation of new families of biologically active 2,5,6-trisubstituted 2-aminobenzothiazoles was carried out by many researchers. For this purpose, the starting 5,6-substituted derivatives of 2-aminobenzothiazole were synthesized from readily available 3,4-substituted anilines in the presence of KSCN and Br2. The cyclization was carried out in ice-cold AcOH, the reaction product was then acylated with chloroacetyl chloride. The obtained chloroacetamides were used in reactions with various heterocyclic compounds.5,6,1618,21,25 More than 100 examples are described. Thus, Özkay et al.16 synthesized a series of benzothiazole-piperazine derivatives 10 (Scheme 9).

graphic file with name 10593_2021_2914_Sch9_HTML.jpg

Scheme 9

A similar approach was used by Amnerkar et al.7 The synthesis of amines 11 and their azomethines (Schiff bases) 12 included the steps of acylation of 6-substituted 2-aminobenzothiazoles with chloroacetyl chloride in dry PhH, cyclization of the acylation product with thiourea in absolute EtOH, and condensation of amines 11 with various aromatic aldehydes (Scheme 10). In this work, 20 compounds were obtained in 58–79% yields. It was noted that both amines 11 and bases 12 exhibited high and in some cases maximum antibacterial, antifungal, and anthelmintic activity.

graphic file with name 10593_2021_2914_Sch10_HTML.jpg

Scheme 10

Indian scientists11 carried out the synthesis of 6-substituted amide derivatives of 2-aminobenzothiazole 1315 with high anti-inflammatory activity from 2-amino-6-nitrobenzothiazole in three steps. The formation of compounds 1315 proceeds via the acylation of 2-amino-6-nitrobenzothiazole by the action of Ac2O in pyridine, reduction of the nitro group in the acylation product by the action of SnCl2 in H2O followed by substitution of the amino group hydrogen atom by acyl, sulfonyl, or carbimide/thiocarbimide groups (Scheme 11).

graphic file with name 10593_2021_2914_Sch11_HTML.jpg

Scheme 11

Liu et al.35 synthesized disulfonamide derivatives 16 also on the basis of 2-amino-6-nitrobenzothiazole. For this, in the first step, proline activated by EDCl in the presence of DMAP was introduced into the reaction. Subsequent reduction of the nitro group (Fe/HCl) made it possible to obtain acetamide which then underwent sulfonylation at the amino group (Scheme 12).

graphic file with name 10593_2021_2914_Sch12_HTML.jpg

Scheme 12

Thus, it can be concluded based on the generalization of the available literature data that the easy functionalization of the amino group and benzene ring of 2-aminobenzothiazole makes it possible to classify it as highly reactive pharmacophore synthon for the design of potential biologically active compounds. It should also be noted that, along with multistep methods for the synthesis of 2-aminobenzothiazole derivatives, economical one-pot methods with high synthetic potential which are the basis of modern organic synthesis are being increasingly developed.

Footnotes

Translated from Khimiya Geterotsiklicheskikh Soedinenii, 2021, 57(4), 369–373

References

  • 1.(a) Agarwal, S.; Gandhi, D.; Kalal, P. Lett. Org. Chem.2017, 14, 729. (b) Keri, R. S.; Patil, M. R.; Patil, S. A.; Budagumpi, S. Eur. J. Med. Chem.2015, 89, 207. (c) Rouf, A.; Tanyeli, C. Eur. J. Med. Chem. 2015, 97, 911. (d) Asiri, Y. I.; Alsayari, A.; Muhsinah, A. B.; Mabkhot, Y. N.; Hassan, M. Z. J. Pharm. Pharmacol. 2020, 72, 1459. (e) Liu, X.; Dong, Z.-B. Eur. J. Org. Chem.2020, 408.
  • 2.Galochkina AV, Bollikanda RK, Zarubaev VV, Tentler DG, Lavrenteva IN, Slita AV, Chirra N, Kantevari S. Arch. Pharm. Chem. Life Sci. 2019;352:e1800225. doi: 10.1002/ardp.201800225. [DOI] [PubMed] [Google Scholar]
  • 3.Montalvao S, Leino TO, Kiuru PS, Lillsunde K-E, Yli-Kauhaluoma J, Tammela P. Arch. Pharm. Chem. Life Sci. 2016;349:137. doi: 10.1002/ardp.201500365. [DOI] [PubMed] [Google Scholar]
  • 4.Takamatsu Y, Aoki M, Bulut H, Das D, Amano M, Sheri VR, Kovari LC, Hayashi H, Delino NS, Ghosh AK, Mitsuya H. Antimicrob. Agents Chemother. 2019;63:e00372. doi: 10.1128/AAC.00372-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wu H, Bock S, Snitko M, Berger T, Weidner T, Holloway S, Kanitz M, Diederich WE, Steuber H, Walter C, Hofmann D, Weissbrich B, Spannaus R, Acosta EG, Bartenschlager R, Engels B, Schirmeister T, Bodem J. Antimicrob. Agents Chemother. 2015;59:1100. doi: 10.1128/AAC.03543-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Yurttaş L, Özkay Y, Duran M, Turan-Zitouni G, Özdemir A, Cantürk Z, Küçükoğlu K, Kaplancıklı ZA. Phosphorus, Sulfur Silicon Relat. Elem. 2016;191:1166. doi: 10.1080/10426507.2016.1150277. [DOI] [Google Scholar]
  • 7.Amnerkar ND, Bhongade BA, Bhusari KP. Arabian J. Chem. 2015;8:545. doi: 10.1016/j.arabjc.2014.11.034. [DOI] [Google Scholar]
  • 8.Defrenza I, Catalano A, Carocci A, Carrieri A, Muraglia M, Rosato A, Corbo F, Franchini C. J. Heterocycl. Chem. 2015;52:1705. doi: 10.1002/jhet.2222. [DOI] [Google Scholar]
  • 9.Borazjani N, Jarrahpour A, Rad JA, Mohkam M, Behzadi M, Ghasemi Y, Mirzaeinia S, Karbalaei-Heidari HR, Ghanbari MM, Batta G, Turos E. Med. Chem. Res. 2019;28:329. doi: 10.1007/s00044-018-02287-0. [DOI] [Google Scholar]
  • 10.Bala R, Kumari P, Sood S, Kumar V, Singh N, Singh K. J. Heterocycl. Chem. 2018;55:2507. doi: 10.1002/jhet.3282. [DOI] [Google Scholar]
  • 11.Sadhasivam G, Kulanthai K. J. Chem. Pharm. Res. 2015;7:425. [Google Scholar]
  • 12.Tariq S, Alam O, Amir M. Arch. Pharm. Chem. Life Sci. 2018;351:e1700304. doi: 10.1002/ardp.201700304. [DOI] [PubMed] [Google Scholar]
  • 13.Tariq S, Kamboj P, Alam O, Amir M. Bioorg. Chem. 2018;81:630. doi: 10.1016/j.bioorg.2018.09.015. [DOI] [PubMed] [Google Scholar]
  • 14.Kumar V, Sharma S, Husain A. Int. Curr. Pharm. J. 2015;4:457. doi: 10.3329/icpj.v4i12.25597. [DOI] [Google Scholar]
  • 15.Ugwu DI, Okoro UC, Ukoha PO, Gupta A, Okafor SN. J. Enzyme Inhib. Med. Chem. 2018;33:405. doi: 10.1080/14756366.2018.1426573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.(а) Özkay, Ü. D.; Kaya, C.; Çevik, U. A.; Can, Ö. D. Molecules2017, 22, 1490. (b) Özkay, Ü. D.; Can, Ö. D.; Sağlık, B. N.; Çevik, U. A.; Levent, S.; Özkay, Y.; Ilgın, S.; Atlı, Ö. Bioorg. Med. Chem. Lett.2016, 26, 5387. [DOI] [PubMed]
  • 17.Liu D-C, Zhang H-J, Jin C-M, Quan Z-S. Molecules. 2016;21:164. doi: 10.3390/molecules21030164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.(а) Ali, R.; Siddiqui, N. Arch. Pharm. Chem. Life Sci.2015, 348, 254. (b) Murtuja, S.; Shaquiquzzaman, M.; Amir, M. Lett. Drug Des. Discovery2018, 15, 398.
  • 19.Harrouche K, Renard J-F, Bouider N, de Tullio P, Goffin E, Lebrun P, Faury G, Pirotte B, Khelili S. Eur. J. Med. Chem. 2016;115:352. doi: 10.1016/j.ejmech.2016.03.028. [DOI] [PubMed] [Google Scholar]
  • 20.Ibrahim DA, Lasheen DS, Zaky MY, Ibrahim AW, Vullo D, Ceruso M, Supuran CT, El Ella DAA. Bioorg. Med. Chem. 2015;23:4989. doi: 10.1016/j.bmc.2015.05.019. [DOI] [PubMed] [Google Scholar]
  • 21.(а) Hassan, A. Y.; Sarg, M. T.; Hussein, M. J. Heterocycl. Chem.2019, 56, 1437. (b) Narva, S.; Chitti, S.; Amaroju, S.; Goud, S.; Alvala, M.; Bhattacharjee, D.; Jain, N.; Gowri, C. S. K. V. J. Heterocycl. Chem.2019, 56, 520. (c) Yang, M.-L.; Zhang, H.; Wang, W.-W.; Wang, X.-J. J. Heterocycl. Chem. 2018, 55, 360. (d) He, J.; Cai, L.; Chen, Y.; He, Y.; Wang, M.; Tang, J.; Guan, H.; Wang, J.; Peng, X. Radiother. Oncol. 2018, 129, 30. (e) Hu, X.; Li, S.; He, Y.; Ai, P.; Wu, S.; Su, Y.; Li, X.; Cai, L.; Peng, X. Oncotarget2017, 8, 11887.
  • 22.Khan KM, Mesaik MA, Abdalla OM, Rahim F, Soomro S, Halim SA, Mustafa G, Ambreen N, Khalid AS, Taha M, Perveen S, Alam MT, Hameed A, Ul-Haq Z, Ullah H, Rehman ZU, Siddiqui RA, Voelter W. Bioorg. Chem. 2016;64:21. doi: 10.1016/j.bioorg.2015.11.004. [DOI] [PubMed] [Google Scholar]
  • 23.Sarkar S, Siddiqui AA, Saha SJ, De R, Mazumder S, Banerjee C, Iqbal MS, Nag S, Adhikari S, Bandyopadhyay U. Antimicrob. Agents Chemother. 2016;60:4217. doi: 10.1128/AAC.01575-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Sever B, Altıntop MD, Özdemir A, Tabanca N, Estep AS, Becnel JJ, Bloomquist JR. Open Chem. 2019;17:288. doi: 10.1515/chem-2019-0027. [DOI] [Google Scholar]
  • 25.Mao M-Z, Wang H-Y, Wang W, Ning B-K, Li Y-X, Xiong L-X, Li Z-M. Phosphorus, Sulfur Silicon Relat. Elem. 2017;192:42. doi: 10.1080/10426507.2016.1224876. [DOI] [Google Scholar]
  • 26.Che J-Y, Meng X-S, Xu X-Y, Jiang S, Gu Y-C, Shi D-Q. J. Heterocycl. Chem. 2016;53:1494. doi: 10.1002/jhet.2453. [DOI] [Google Scholar]
  • 27.(a) Grebneva, E. A.; Bolgova, Y. I.; Trofimova, O. M.; Albanov, A. I.; Borodina, T. N. Chem. Heterocycl. Compd.2019, 55, 762. [Khim. Geterotsikl. Soedin.2019, 55, 762.] (b) Zhilitskaya, L. V.; Yarosh, N. O.; Shagun, L. G.; Dorofeev, I. A.; Larina, L. I. Chem. Heterocycl. Compd. 2015, 51, 381. [Khim. Geterotsikl. Soedin.2015, 51, 381.] (c) Zhilitskaya, L. V.; Shagun, L. G.; Dorofeev, I. A.; Yarosh, N. O. Chem. Heterocycl. Compd. 2019, 55, 888. [Khim. Geterotsikl. Soedin.2019, 55, 888.] (d) Shagun, L. G.; Dorofeev, I. А.; Zhilitskaya, L. V.; Yarosh, N. О.; Larina, L. I. Russ. J. Org. Chem. 2018, 54, 1228. [Zh. Org. Khim.2018, 54, 1215.] (e) Shagun, L. G.; Dorofeev, I. А.; Zhilitskaya, L. V.; Yarosh, N. О.; Larina, L. I. Russ. J. Org. Chem. 2019, 55, 983. [Zh. Org. Khim.2019, 55, 1084.] (f) Zhilitskaya, L. V.; Yarosh, N. O.; Shagun, L. G.; Dorofeev, I. A. Russ. J. Gen. Chem. 2020, 90, 1235. [Zh. Obsh. Khim.2020, 90, 1047.]
  • 28.(a) Yarosh, N. O.; Zhilitskaya, L. V.; Shagun, L. G.; Dorofeev, I. A. Russ. J. Org. Chem. 2020, 56, 833. [Zh. Org. Khim.2020, 56, 789.] (b) Zhilitskaya, L. V.; Yarosh, N. O.; Shagun, L. G.; Dorofeev, I. A.; Larina, L. I. Mendeleev Commun. 2017, 27, 352. (c) Yarosh, N. O.; Zhilitskaya, L. V.; Shagun, L. G.; Dorofeev, I. A.; Larina, L. I. Russ. J. Org. Chem. 2019, 55, 1071. [Zh. Org. Khim.2019, 55, 1157.] (d) Lyubchuk, T. V.; Hordiyenko, O. V. Chem. Heterocycl. Compd.2020, 56, 1. [Khim. Geterotsikl. Soedin.2020, 56, 1.]
  • 29.(a) Kitanosono, T.; Masuda, K.; Xu, P.; Kobayashi, S. Chem. Rev. 2018, 118, 679. (b) Chen, Z.; Ren, H. Solvents as Reagents in Organic Synthesis: Reactions and Applications; Wu, X.-F., Ed.; Wiley, 2018, p. 1. [DOI] [PubMed]
  • 30.Gajaganti S, Kumari S, Kumar D, Allam BK, Srivastava V, Singh S. J. Heterocycl. Chem. 2018;55:2578. doi: 10.1002/jhet.3314. [DOI] [Google Scholar]
  • 31.Khan T, Yadav R. J. Heterocycl. Chem. 2019;56:11. doi: 10.1002/jhet.3334. [DOI] [Google Scholar]
  • 32.Nouri A, Marjani AP, Khalafy J. J. Heterocycl. Chem. 2019;56:2912. doi: 10.1002/jhet.3685. [DOI] [Google Scholar]
  • 33.Kumar M, Arya AK, George J, Arya K, Pardasani RT. J. Heterocycl. Chem. 2017;54:3418. doi: 10.1002/jhet.2964. [DOI] [Google Scholar]
  • 34.Arab-Salmanabadi S. J. Heterocycl. Chem. 2017;54:3600. doi: 10.1002/jhet.2986. [DOI] [Google Scholar]
  • 35.Liu N, Zhu S, Zhang X, Yin X, Dong G, Yao J, Miao Z, Zhang W, Zhang X. Sheng. C. Chem. Commun. 2016;52:3340. doi: 10.1039/C5CC10594C. [DOI] [PubMed] [Google Scholar]

Articles from Chemistry of Heterocyclic Compounds are provided here courtesy of Nature Publishing Group

RESOURCES